These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


221 related items for PubMed ID: 17704514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diffusion of levofloxacin into bone and synovial tissues.
    Rimmelé T, Boselli E, Breilh D, Djabarouti S, Bel JC, Guyot R, Saux MC, Allaouchiche B.
    J Antimicrob Chemother; 2004 Mar; 53(3):533-5. PubMed ID: 14963066
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion.
    Breilh D, Fleureau C, Gordien JB, Joanes-Boyau O, Texier-Maugein J, Rapaport S, Boselli E, Janvier G, Saux MC.
    Minerva Anestesiol; 2011 Nov; 77(11):1058-62. PubMed ID: 21597443
    [Abstract] [Full Text] [Related]

  • 5. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose.
    Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ.
    J Antimicrob Chemother; 2006 Dec; 58(6):1221-9. PubMed ID: 17012300
    [Abstract] [Full Text] [Related]

  • 6. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
    Burkhardt O, Kumar V, Katterwe D, Majcher-Peszynska J, Drewelow B, Derendorf H, Welte T.
    J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Penetration of ertapenem into different pulmonary compartments of patients undergoing lung surgery.
    Burkhardt O, Majcher-Peszynska J, Borner K, Mundkowski R, Drewelow B, Derendorf H, Welte T.
    J Clin Pharmacol; 2005 Jun; 45(6):659-65. PubMed ID: 15901747
    [Abstract] [Full Text] [Related]

  • 10. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R, Burian B, Burian A, Jäger W, Höferl M, Stella A, Theurer S, Riedl M, Zeitlinger M.
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [Abstract] [Full Text] [Related]

  • 11. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
    Burkhardt O, Brunner M, Schmidt S, Grant M, Tang Y, Derendorf H.
    J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
    [Abstract] [Full Text] [Related]

  • 12. Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties.
    Hammond ML.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii7-9. PubMed ID: 15150178
    [Abstract] [Full Text] [Related]

  • 13. Gentamicin concentrations in synovial fluid and joint tissues during intravenous administration or continuous intra-articular infusion of the tarsocrural joint of clinically normal horses.
    Lescun TB, Ward MP, Adams SB.
    Am J Vet Res; 2006 Mar; 67(3):409-16. PubMed ID: 16506901
    [Abstract] [Full Text] [Related]

  • 14. Ceftriaxone bone penetration in patients with septic non-union of the tibia.
    Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Massè A, Di Perri G.
    Int J Infect Dis; 2011 Jun; 15(6):e415-21. PubMed ID: 21497532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
    Ober MC, Hoppe-Tichy T, Köninger J, Schunter O, Sonntag HG, Weigand MA, Encke J, Gutt C, Swoboda S.
    J Antimicrob Chemother; 2009 Nov; 64(5):1091-5. PubMed ID: 19734170
    [Abstract] [Full Text] [Related]

  • 18. [Characteristics of ertapenem use in critical state patients].
    Beloborodov VB.
    Antibiot Khimioter; 2011 Nov; 56(3-4):10-2, 14-6. PubMed ID: 21913404
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
    Lemaire S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM.
    J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.